Annual Long Term Debt
$2.36 M
+$1.43 M+154.42%
December 1, 2024
Summary
- As of March 10, 2025, CLDX annual long term debt is $2.36 million, with the most recent change of +$1.43 million (+154.42%) on December 1, 2024.
- During the last 3 years, CLDX annual long term debt has risen by +$1.06 million (+82.18%).
- CLDX annual long term debt is now -73.79% below its all-time high of $9.01 million, reached on December 31, 2011.
Performance
CLDX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$2.36 M
+$653.00 K+38.23%
December 1, 2024
Summary
- As of March 10, 2025, CLDX quarterly long term debt is $2.36 million, with the most recent change of +$653.00 thousand (+38.23%) on December 1, 2024.
- Over the past year, CLDX quarterly long term debt has stayed the same.
- CLDX quarterly long term debt is now -79.82% below its all-time high of $11.70 million, reached on March 31, 2011.
Performance
CLDX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CLDX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +154.4% | 0.0% |
| 3 y3 years | +82.2% | 0.0% |
| 5 y5 years | +37.8% | 0.0% |
CLDX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.8% | +154.4% | -8.8% | +402.3% |
| 5 y | 5-year | -8.8% | +154.4% | -8.8% | +402.3% |
| alltime | all time | -73.8% | -100.0% | -79.8% | -100.0% |
Celldex Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.36 M(+154.4%) | $2.36 M(+38.2%) |
| Sep 2024 | - | $1.71 M(+114.6%) |
| Jun 2024 | - | $796.00 K(+69.4%) |
| Mar 2024 | - | $470.00 K(-49.4%) |
| Dec 2023 | $928.00 K(-64.1%) | $928.00 K(-28.6%) |
| Sep 2023 | - | $1.30 M(-24.7%) |
| Jun 2023 | - | $1.73 M(-20.0%) |
| Mar 2023 | - | $2.16 M(-16.7%) |
| Dec 2022 | $2.59 M(+99.7%) | $2.59 M(+18.2%) |
| Sep 2022 | - | $2.19 M(-15.3%) |
| Jun 2022 | - | $2.59 M(+207.5%) |
| Mar 2022 | - | $841.00 K(-35.1%) |
| Dec 2021 | $1.30 M(-39.8%) | $1.30 M(-24.3%) |
| Sep 2021 | - | $1.71 M(+18.5%) |
| Jun 2021 | - | $1.45 M(-18.0%) |
| Mar 2021 | - | $1.76 M(-18.1%) |
| Dec 2020 | $2.15 M(+25.7%) | $2.15 M(-15.4%) |
| Sep 2020 | - | $2.54 M(+48.0%) |
| Jun 2020 | - | $1.72 M(-18.3%) |
| Mar 2020 | - | $2.11 M(+22.9%) |
| Dec 2019 | $1.71 M(>+9900.0%) | $1.71 M(+15.6%) |
| Sep 2019 | - | $1.48 M(-20.6%) |
| Jun 2019 | - | $1.87 M(-28.2%) |
| Mar 2019 | - | $2.60 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2013 | - | $4.43 M(-23.0%) |
| Dec 2012 | $5.75 M(-36.2%) | $5.75 M(-21.6%) |
| Sep 2012 | - | $7.33 M(-14.9%) |
| Jun 2012 | - | $8.61 M(-13.0%) |
| Mar 2012 | - | $9.89 M(+9.8%) |
| Dec 2011 | $9.01 M | $9.01 M(-18.2%) |
| Sep 2011 | - | $11.02 M(+3.7%) |
| Jun 2011 | - | $10.62 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2011 | - | $11.70 M(+31.6%) |
| Dec 2010 | $8.89 M(+113.4%) | $8.89 M(+5579.9%) |
| Mar 2009 | - | $156.50 K(-80.1%) |
| Sep 2008 | - | $786.90 K(-7.2%) |
| Jun 2008 | - | $847.60 K(-6.6%) |
| Mar 2008 | - | $907.80 K(-79.9%) |
| Mar 2007 | - | $4.52 M(+8.4%) |
| Dec 2006 | $4.17 M(+122.7%) | $4.17 M(+107.8%) |
| Mar 2006 | - | $2.00 M(+7.2%) |
| Dec 2005 | $1.87 M(+594.7%) | $1.87 M(+4010.1%) |
| Sep 2000 | - | $45.50 K(-61.7%) |
| Jun 2000 | - | $118.90 K(-39.3%) |
| Mar 2000 | - | $195.80 K(-27.3%) |
| Dec 1999 | $269.20 K(-55.1%) | $269.20 K(-32.7%) |
| Sep 1999 | - | $400.00 K(0.0%) |
| Jun 1999 | - | $400.00 K(-20.0%) |
| Mar 1999 | - | $500.00 K(-16.7%) |
| Dec 1998 | $600.00 K(-25.0%) | $600.00 K(-25.0%) |
| Sep 1998 | - | $800.00 K(0.0%) |
| Jun 1998 | - | $800.00 K(0.0%) |
| Mar 1998 | - | $800.00 K(0.0%) |
| Dec 1997 | $800.00 K(+300.0%) | $800.00 K(+300.0%) |
| Sep 1996 | - | $200.00 K(0.0%) |
| Jun 1996 | - | $200.00 K(0.0%) |
| Mar 1996 | - | $200.00 K(0.0%) |
| Dec 1995 | $200.00 K(-60.0%) | $200.00 K(0.0%) |
| Sep 1995 | - | $200.00 K(0.0%) |
| Jun 1995 | - | $200.00 K(-60.0%) |
| Mar 1995 | - | $500.00 K(0.0%) |
| Dec 1994 | $500.00 K(0.0%) | $500.00 K(0.0%) |
| Sep 1994 | - | $500.00 K(0.0%) |
| Jun 1994 | - | $500.00 K(0.0%) |
| Mar 1994 | - | $500.00 K(0.0%) |
| Dec 1993 | $500.00 K | $500.00 K |
FAQ
- What is Celldex Therapeutics annual long term debt?
- What is the all time high annual long term debt for Celldex Therapeutics?
- What is Celldex Therapeutics annual long term debt year-on-year change?
- What is Celldex Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly long term debt year-on-year change?
What is Celldex Therapeutics annual long term debt?
The current annual long term debt of CLDX is $2.36 M
What is the all time high annual long term debt for Celldex Therapeutics?
Celldex Therapeutics all-time high annual long term debt is $9.01 M
What is Celldex Therapeutics annual long term debt year-on-year change?
Over the past year, CLDX annual long term debt has changed by +$1.43 M (+154.42%)
What is Celldex Therapeutics quarterly long term debt?
The current quarterly long term debt of CLDX is $2.36 M
What is the all time high quarterly long term debt for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly long term debt is $11.70 M
What is Celldex Therapeutics quarterly long term debt year-on-year change?
Over the past year, CLDX quarterly long term debt has changed by $0.00 (0.00%)